The clinical practice guideline on the treatment of tuberculosis, published in the November 15, 2019, issue of the *Journal* ([@bib1]), contains several errors. On page e124, the first sentence under the heading A[dditional]{.smallcaps} C[onsiderations]{.smallcaps} as well as the first full sentence in the middle column should have contained "less than" symbols instead of "greater than" symbols. Here are the corrected sentences:"When applying the eligibility criteria from WHO for using the shorter-course, standardized regimen to the population included in our PS-matched IPDMA (7, 253), \<15% of individuals would have been eligible for the standardized, shorter regimen.In the United States, \<15% of patients with MDR-TB would be eligible for the shorter-course MDR-TB regimen (256)."

On page e103, the penultimate sentence in the middle column should read:"To reflect meaningful variations in the duration of the intensive regimen after conversion, stratified analyses were conducted: strata were 0 to 1.0 months, 1.01 to 3.0 months, 3.01 to 5.0 months, 5.01 to 7.0 months, and **7.01 \[not 7.1\]** to 15.0 months (*see* Table 5)."

Finally, on page e130, third column, the reference number at the end of the first sentence of the B[enefits]{.smallcaps} section should be 333 (not 290). For the convenience of our readers, the *Journal* is replacing the online version of the article with a corrected version; we apologize for the errors. There are no changes in the executive summary of the guideline.
